Godavari Biorefineries has informed that the Japanese Patent Office granted its patent, ‘5-HYDROXY1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER’. This patent covers a novel class of compounds that exhibit strong inhibitory effects on cancer and cancer stem cells, demonstrating significant efficacy against multiple types, including breast and prostate cancer. Grant Certificate is attached.
The above information is a part of company’s filings submitted to BSE.